Your browser doesn't support javascript.
loading
The Role of VEGF Family in Lipid Metabolism.
Zhou, Yan; Zhu, Xueping; Wang, Huan; Duan, Chenglin; Cui, Hanming; Shi, Jingjing; Shi, Shuai; Yuan, Guozhen; Hu, Yuanhui.
Afiliação
  • Zhou Y; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhu X; Beijing University of Chinese Medicine, Beijing, China.
  • Wang H; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Duan C; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Cui H; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Shi J; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Shi S; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Yuan G; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Hu Y; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Curr Pharm Biotechnol ; 24(2): 253-265, 2023.
Article em En | MEDLINE | ID: mdl-35524661
The vascular endothelial growth factor (VEGF) family plays a major role in tumors and ophthalmic diseases. However, increasingly more data reported its potential in regulating lipids. With its biological functions mainly expressed in lymphatic vessels, some factors in the families, like VEGF-A and VEGF-C, have been proved to regulate intestinal absorption of lipids by affecting chylous ducts. Other effects, including regulating lipoprotein lipase (LPL), endothelial lipase (EL), and recombinant syndecan 1 (SDC1), have also been confirmed. However, given the scant-related studies, further research should be conducted to examine the concrete mechanisms and provide pragmatic ways to apply them in the clinic. The VEGF family may treat dyslipidemia in specific ways that are different from common methods and concurrently contribute to the treatment of other metabolic diseases, like diabetes and obesity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator A de Crescimento do Endotélio Vascular / Metabolismo dos Lipídeos Limite: Humans Idioma: En Revista: Curr Pharm Biotechnol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator A de Crescimento do Endotélio Vascular / Metabolismo dos Lipídeos Limite: Humans Idioma: En Revista: Curr Pharm Biotechnol Ano de publicação: 2023 Tipo de documento: Article